LEXX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
LEXX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-05-21), Lexaria Bioscience's current share price is $2.9426. Lexaria Bioscience's Cyclically Adjusted Book per Share for the quarter that ended in Feb. 2024 was $1.28. Lexaria Bioscience's Cyclically Adjusted PB Ratio for today is 2.30.
The historical rank and industry rank for Lexaria Bioscience's Cyclically Adjusted PB Ratio or its related term are showing as below:
During the past years, Lexaria Bioscience's highest Cyclically Adjusted PB Ratio was 16.10. The lowest was 0.37. And the median was 2.48.
LEXX's Cyclically Adjusted PB Ratio is ranked worse thanThe Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.
Lexaria Bioscience's adjusted book value per share data for the three months ended in Feb. 2024 was $0.526. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $1.28 for the trailing ten years ended in Feb. 2024.
The historical data trend for Lexaria Bioscience's Cyclically Adjusted PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lexaria Bioscience Quarterly Data | ||||||||||||||||||||
May19 | Aug19 | Nov19 | Feb20 | May20 | Aug20 | Nov20 | Feb21 | May21 | Aug21 | Nov21 | Feb22 | May22 | Aug22 | Nov22 | Feb23 | May23 | Aug23 | Nov23 | Feb24 | |
Cyclically Adjusted PB Ratio | Get a 7-Day Free Trial | 1.84 | 0.47 | 0.71 | 1.09 | 2.70 |
For the Biotechnology subindustry, Lexaria Bioscience's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Lexaria Bioscience's Cyclically Adjusted PB Ratio distribution charts can be found below:
* The bar in red indicates where Lexaria Bioscience's Cyclically Adjusted PB Ratio falls into.
Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.
Lexaria Bioscience's Cyclically Adjusted PB Ratio for today is calculated as
Cyclically Adjusted PB Ratio | = | Share Price | / | Cyclically Adjusted Book per Share |
= | 2.9426 | / | 1.28 | |
= | 2.30 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lexaria Bioscience's Cyclically Adjusted Book per Share for the quarter that ended in Feb. 2024 is calculated as:
For example, Lexaria Bioscience's adjusted Book Value per Share data for the three months ended in Feb. 2024 was:
Adj_Book | = | Book Value per Share | / | CPI of Feb. 2024 (Change) | * | Current CPI (Feb. 2024) |
= | 0.526 | / | 125.4675 | * | 125.4675 | |
= | 0.526 |
Current CPI (Feb. 2024) = 125.4675.
Lexaria Bioscience Quarterly Data
Book Value per Share | CPI | Adj_Book | |
201404 | 3.198 | 98.920 | 4.056 |
201407 | 2.950 | 99.315 | 3.727 |
201411 | 1.121 | 99.078 | 1.420 |
201502 | 0.900 | 99.078 | 1.140 |
201505 | 0.792 | 100.263 | 0.991 |
201508 | 0.528 | 100.579 | 0.659 |
201511 | 0.317 | 100.421 | 0.396 |
201602 | 0.178 | 100.421 | 0.222 |
201605 | 0.080 | 101.765 | 0.099 |
201608 | 0.156 | 101.686 | 0.192 |
201611 | 0.440 | 101.607 | 0.543 |
201702 | 0.368 | 102.476 | 0.451 |
201705 | 1.472 | 103.108 | 1.791 |
201708 | 1.327 | 103.108 | 1.615 |
201711 | 1.038 | 103.740 | 1.255 |
201802 | 1.170 | 104.688 | 1.402 |
201805 | 1.093 | 105.399 | 1.301 |
201808 | 0.948 | 106.031 | 1.122 |
201811 | 1.328 | 105.478 | 1.580 |
201902 | 1.069 | 106.268 | 1.262 |
201905 | 1.216 | 107.927 | 1.414 |
201908 | 0.907 | 108.085 | 1.053 |
201911 | 0.940 | 107.769 | 1.094 |
202002 | 0.699 | 108.559 | 0.808 |
202005 | 1.067 | 107.532 | 1.245 |
202008 | 0.841 | 108.243 | 0.975 |
202011 | 0.626 | 108.796 | 0.722 |
202102 | 2.306 | 109.745 | 2.636 |
202105 | 2.027 | 111.404 | 2.283 |
202108 | 2.317 | 112.668 | 2.580 |
202111 | 2.040 | 113.932 | 2.247 |
202202 | 1.925 | 115.986 | 2.082 |
202205 | 1.543 | 120.016 | 1.613 |
202208 | 1.336 | 120.569 | 1.390 |
202211 | 1.052 | 121.675 | 1.085 |
202302 | 0.836 | 122.070 | 0.859 |
202305 | 0.543 | 124.045 | 0.549 |
202308 | 0.376 | 125.389 | 0.376 |
202311 | 0.363 | 125.468 | 0.363 |
202402 | 0.526 | 125.468 | 0.526 |
Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.
Thank you for viewing the detailed overview of Lexaria Bioscience's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Catherine C. Turkel | director | 19900 MACARTHUR BLVD., SUITE 550, IRVINE CA 92612 |
Gregory Downey | officer: Chief Financial Officer | 100 - 740 MCCURDY ROAD, KELOWNA A1 V1X 2P7 |
Christopher Bunka | director, 10 percent owner, officer: CEO | 1924 BIRKDALE AVE, KELOWNA A1 V1P1R7 |
Vanessa Carle | officer: Secretary | 100 - 740 MCCURDY ROAD, KELOWNA A1 V1X 2P7 |
Reese Albert L Jr | director | |
Brian W. Quigley | director | 100 740 MCCURDY ROAD, KELOWNA A1 23230 |
William Edward Mckechnie | director | 305 MARGARET AVENUE, KITCHENER A6 N2H 6S4 |
Allan Horst Spissinger | officer: CFO | 8131 198A STREET, LANGLEY A1 V2Y 1Y6 |
John Martin Docherty | director, 10 percent owner | 23 MIKELEN DRIVE, PORT PERRY A6 L9L 1V1 |
Baljinder Bhullar | director, officer: CFO | 604 - 700 WEST PENDER, VANCOUVER A1 V6C 1G8 |
Nicholas W Baxter | director | 220 SPRINGFIELD ROAD, ABERDEEN, ABERDEENSHIRE, SCOTLAND X0 AB15 6AU |
Dustin Arthur Elford | director | 888 - 609 WEST HASTINGS STREET, VANCOUVER A1 V6B 4W4 |
Thomas James Ihrke | officer: Sr. VP, Business Development | 38 KRIER LANE, MOUNT PLEASANT SC 29464 |
David Demartini | director, 10 percent owner | 11714 SPRIGGS WAY, HOUSTON TX 77024 |
Leonard Macmillan | director, officer: Vice President - Corp Develop | SUITE 302, 125A - 1030 DENMAN STREET, VANCOUVER A1 V6G 2M6 |
From GuruFocus
By ACCESSWIRE • 08-02-2023
By ACCESSWIRE ACCESSWIRE • 05-09-2023
By ACCESSWIRE • 06-22-2023
By ACCESSWIRE ACCESSWIRE • 06-16-2023
By ACCESSWIRE • 08-09-2023
By ACCESSWIRE • 09-29-2023
By ACCESSWIRE • 01-24-2024
By ACCESSWIRE ACCESSWIRE • 05-11-2023
By ACCESSWIRE • 07-19-2023
By ACCESSWIRE ACCESSWIRE • 05-08-2023